Potomac Capital Management’s DNA X SONM Stock Holding History
Bought
Maintained
Sold
Other funds holding SONM
Potomac Capital Management's SONM Position: Q1 2026 in Review
Potomac Capital Management sold out of DNA X (SONM) in Q1 2026, closing a stake of 48,000 shares — an estimated $151K sold.
Potomac Capital Management first reported a position in SONM in Q4 2025 and held it in 1 quarter. The position peaked at $151K in Q4 2025. 9 funds tracked by Wall St. Rank hold SONM as of Q1 2026.
- Potomac Capital Management reported no remaining DNA X position as of Q1 2026 after selling out during the quarter.
- Potomac Capital Management sold 48,000 DNA X shares in Q1 2026, an estimated $151K.
- Potomac Capital Management first reported a position in DNA X in Q4 2025 and held it in 1 quarter.
- Potomac Capital Management's DNA X position peaked at $151K in Q4 2025.
- 9 funds tracked by Wall St. Rank held DNA X as of Q1 2026.
Based on Potomac Capital Management's 13F filing for Q1 2026, filed 14 May 2026.